Codagenix scores again: $3M to hunt down deadly RSV
By GREGORY ZELLER // A fresh $3 million in public and private investments has set Codagenix Inc. on the trail of another nefarious disease. Already developing vaccines for Zika virus,…
By GREGORY ZELLER // A fresh $3 million in public and private investments has set Codagenix Inc. on the trail of another nefarious disease. Already developing vaccines for Zika virus,…
By GREGORY ZELLER // A biotech manufacturer with a 23-year history of servicing Stony Brook University researchers and startups is being evicted from the university’s Chemistry Building – and nobody…
By GREGORY ZELLER // New York has launched a “groundbreaking” $650 million initiative to support life-science industries across the state. The initiative, announced Monday, will offer investment capital, operating support…
A year of big steps has led to one giant leap for Codagenix. Stony Brook University, through the Research Foundation for the State University of New York, has entered into…
By GREGORY ZELLER // Be afraid, Zika virus. With 1,500 square feet of new wet-lab space and buckets of confidence, the big thinkers at Codagenix are targeting your chemical code…
By GREGOERY ZELLER // A seven-figure Regional Economic Development Council award is set to push an innovative influenza vaccine toward human trials. Codagenix, a 2012 startup cofounded by Farmingdale State…
A Long Island lifer – he earned an undergraduate degree at C.W. Post and an MBA at Adelphi University before serving as president of the Lake Success-based subsidiary of Norwegian…
Biotech firm Codagenix, a fixture at Stony Brook’s technology incubator for the past three years, is moving to the Broad Hollow Bioscience Park at SUNY Farmingdale to qualify for the…